Pihlstrøm, L;
Wiethoff, S;
Houlden, H;
(2018)
Genetics of neurodegenerative diseases: an overview.
Handbook of Clinical Neurology
, 145
pp. 309-323.
10.1016/B978-0-12-802395-2.00022-5.
Text
Wiethoff NeurodegenGeneticsOverview_Manuscript_0902.pdf - Accepted Version Access restricted to UCL open access staff Download (595kB) |
|
Image
AD_PD_overview_figure.png - Accepted Version Access restricted to UCL open access staff Download (310kB) |
|
Image
Timeline_NeurodegenGenetics.png - Accepted Version Access restricted to UCL open access staff Download (148kB) |
Abstract
Genetic factors are central to the aetiology of neurodegeneration, both as monogenic causes of heritable disease and as modifiers of susceptibility to complex, sporadic disorders. Over the last two decades, the identification of disease genes and risk loci has led to some of the greatest advances in medicine and invaluable insights into pathogenic mechanisms and disease pathways. Large-scale research efforts, novel study designs and advances in methodology are rapidly expanding our understanding of the genome and the genetic architecture of neurodegenerative disease. Here, we review major developments in the field to date, highlighting overarching historical trends and general insights. Monogenic neurodegenerative diseases are discussed from the perspectives of both rare Mendelian forms of common disorders, such as Alzheimer's disease and Parkinson's disease, and heterogeneous heritable conditions, including ataxias and spastic paraplegias. Next, we summarize the experiences from investigations of complex neurodegenerative disorders, including genome-wide association studies. In the final section, we reflect upon the limitations of current findings and outline important future directions. Genetics plays an essential role in translational research, ultimately aiming to develop novel disease-modifying therapies for neurodegenerative disorders. We anticipate that individual genetic profiling will also be increasingly relevant in a clinical context, with implications for patient care in line with the proposed ideal of personalized medicine.
Archive Staff Only
View Item |